T-226296: a novel, orally active and selective melanin-concentrating hormone receptor antagonist

Author： Takekawa S.   Asami A.   Ishihara Y.   Terauchi J.   Kato K.   Shimomura Y.   Mori M.   Murakoshi H.   Kato K.   Suzuki N.   Nishimura O.   Fujino M.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.438, Iss.3, 2002-03, pp. : 129-135

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Does the melanin-concentrating hormone antagonist SNAP-7941 deserve 3As?

By Doggrell Sheila A  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 6, 2003-06 ,pp. : 1035-1038

Informa Healthcare

Access to resources Recommend Favorite

Discovery and development of melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity

By Rokosz Laura L  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 10, 2007-10 ,pp. : 1301-1327

Informa Healthcare

Access to resources Recommend Favorite

Recent progress in the discovery of melanin-concentrating hormone 1-receptor antagonists

By Johansson Anders  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 6, 2011-06 ,pp. : 905-925

Informa Healthcare

Access to resources Recommend Favorite

Melanin-concentrating hormone receptor antagonists as potential antiobesity agents

By Carpenter Andrew J   Hertzog Donald L  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 11, 2002-11 ,pp. : 1639-1646

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of melanin-concentrating hormone-1 receptor antagonists for the treatment of obesity

By Kowalski Timothy J   McBriar Mark D  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 9, 2004-09 ,pp. : 1113-1122

Informa Healthcare

Access to resources Recommend Favorite